CalRx Biosimilar Insulin: California's Initiative to Enter the Insulin Market

被引：2
|
作者：
Feldman, Robin [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Coll Law San Francisco, San Francisco, CA USA
[2] Univ Calif San Francisco, Coll Law San Francisco, 200 McAllister St, San Francisco, CA 94102 USA
来源：
JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 10期
关键词：
D O I：
10.1001/jamainternmed.2023.3280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This viewpoint evaluates California's CalRx Biosimilar Insulin Initiative, which aims to address insulin affordability by offering less expensive alternatives to existing products, specifically targeting patients with insulin-dependent diabetes.
引用
收藏
页码：1043 / 1044
页数：2
相关论文
共 50 条
  • [1] Assessing-and Extending-California's Insulin Manufacturing Initiative
    Sherkow, Jacob S.
    Adashi, Eli Y.
    Cohen, I. Glenn
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (07): : 533 - 534
  • [2] Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market
    Levy, Joseph
    Chowdhury, Zahra M.
    Socal, Mariana P.
    Trujillo, Antonio J.
    JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1405 - +
  • [3] Biosimilar insulin concepts
    Bloomgarden, Zachary T.
    JOURNAL OF DIABETES, 2022, 14 (04) : 231 - 235
  • [4] First insulin biosimilar
    Nature Biotechnology, 2014, 32 (8) : 707 - 707
  • [5] Effect of biosimilar basaglar entry in the long-acting insulin market
    Rashidi, Emaan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 407 - 407
  • [6] First biosimilar drug set to enter US market
    Heidi Ledford
    Nature, 2015, 517 : 253 - 254
  • [7] FORECASTING SOCIAL WELFARE GAINSFFROM BIOSIMILAR ENTRIES IN THE BASAL INSULIN MARKET
    Li, C.
    Yu, T.
    Jin, S.
    Hlavka, J.
    VALUE IN HEALTH, 2022, 25 (12) : S145 - S145
  • [8] First biosimilar drug set to enter US market
    Ledford, Heidi
    NATURE, 2015, 517 (7534) : 253 - 254
  • [9] Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative
    Socal, Mariana P.
    Estus, Emily
    Long, Jingmiao
    Crane, Matthew A.
    Pegany, Vishaal
    Anderson, Gerard F.
    VALUE IN HEALTH, 2023, 26 (05) : 634 - 638
  • [10] The First Interchangeable Biosimilar Insulin: Insulin Glargine-yfgn
    Matli, Mark C.
    Wilson, Andrea B.
    Rappsilber, Leah M.
    Sheffield, Farron P.
    Farlow, Miranda L.
    Johnson, Jeremy L.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (02): : 490 - 494
12345